ResearcherTongji UniversityNo recent work listed
Rui Lin
Matched on ORCID iD 0000-0002-3197-9798; OpenAlex author ID A5101525433. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper
Papers 5
- Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting mi… Co-author DOI 10.1016/j.drup.2023.100960↗
- TRPM2 promotes pancreatic cancer by PKC/MAPK pathway. Co-author DOI 10.1038/s41419-021-03856-9↗
- Human Mesenchymal Stem Cell-Derived Exosomal microRNA-143 Promotes Apoptosis and Suppresses Cell Growth in Pancreatic Cancer via Target Gene Regulation. Co-author DOI 10.3389/fgene.2021.581694↗
- Anticancer effects of miR-124 delivered by BM-MSC derived exosomes on cell proliferation, epithelial mesenchymal transition, and chemotherapy sensitivity of pa… Co-author DOI 10.18632/aging.103997↗
- TRPM2 promotes the proliferation and invasion of pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/mmr.2018.8816↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Baomin Shi · 3 shared papers, 2018–2023 · strength 0.39
- Paper Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secr… DOI 10.1016/j.drup.2023.100960↗
- Paper TRPM2 promotes pancreatic cancer by PKC/MAPK pathway. DOI 10.1038/s41419-021-03856-9↗
- Paper TRPM2 promotes the proliferation and invasion of pancreatic ductal adenocarcinoma. DOI 10.3892/mmr.2018.8816↗
- Baomin Shi · 2 shared papers, 2020–2021 · strength 0.27
- Paper Human Mesenchymal Stem Cell-Derived Exosomal microRNA-143 Promotes Apoptosis and Suppresses Cell Growth in Pancreatic C… DOI 10.3389/fgene.2021.581694↗
- Paper Anticancer effects of miR-124 delivered by BM-MSC derived exosomes on cell proliferation, epithelial mesenchymal transi… DOI 10.18632/aging.103997↗
- Yufeng Wang · 2 shared papers, 2018–2023 · strength 0.25
- Ran Qi · 1 shared paper, 2023 · strength 0.16
- Kaixing Ai · 1 shared paper, 2021 · strength 0.14
- Bingyi Wang · 1 shared paper, 2021 · strength 0.14
- Yan Xu · 1 shared paper, 2020 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.